Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Patients meeting March 2018
January 11, 2019
Patients meeting 8th AAA, Lisbon February 2018
January 11, 2019
Patients & Carers meeting December 2017
January 11, 2019
Patients & Carers meeting November 2017
January 11, 2019
Patients & Carers meeting October 2017
January 11, 2019
Patients & Carers meeting September 2017
January 11, 2019
Patients & Carers meeting August 2017
January 11, 2019
Patients & Carers meeting July 2017
January 11, 2019
Patients & Carers meeting June 2017
January 11, 2019
Patients & Carers meeting May 2017
January 11, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video